JPS6450896A - Contraction suppressing peptide - Google Patents
Contraction suppressing peptideInfo
- Publication number
- JPS6450896A JPS6450896A JP62207784A JP20778487A JPS6450896A JP S6450896 A JPS6450896 A JP S6450896A JP 62207784 A JP62207784 A JP 62207784A JP 20778487 A JP20778487 A JP 20778487A JP S6450896 A JPS6450896 A JP S6450896A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- protecting group
- amino
- group
- cha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
NEW MATERIAL:A peptideamide expressed by the formula [X is Gly, D(L)-Ala, D(L)-Asn, D(L)-Gln, etc.; CHA is cyclohexylamidated product of carboxyl group of amino acid.; n is 1 or 2; m is 0 or 1]. USE:A muscle contraction suppressing agent. PREPARATION:For example, the formula Z-Arg(NO2)-OH (Z is protecting group of amino group) activated in a solvent is reacted with the formula D-Ala- CHA.HCl and then the resultant compound is reduced with hydrogen in the presence of Pd-black and protecting group is removed to give the formula Arg-D-Ala-CHA, which is then dissolved in water and reacted with the formula Boc-Met-OH (Boc is protecting group of amino group) and the amino protecting group is removed and then the solution is reacted with the formula PMZ-Phe-OH (PMZ is protecting group of amino group) and amino protecting group is removed to provide the compound expressed by the formula.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62207784A JPS6450896A (en) | 1987-08-20 | 1987-08-20 | Contraction suppressing peptide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62207784A JPS6450896A (en) | 1987-08-20 | 1987-08-20 | Contraction suppressing peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS6450896A true JPS6450896A (en) | 1989-02-27 |
Family
ID=16545448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62207784A Pending JPS6450896A (en) | 1987-08-20 | 1987-08-20 | Contraction suppressing peptide |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6450896A (en) |
-
1987
- 1987-08-20 JP JP62207784A patent/JPS6450896A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3926938A (en) | Synthesis of salmon calcitonin | |
| US3929758A (en) | Cyclization of cysteine-containing peptides | |
| NO912438L (en) | HUMANINSULINANALOGER. | |
| CA1106360A (en) | Antigenically active polypeptide and a process for its preparation | |
| PT83278A (en) | Process for the preparation of insulin analogues and of injectable insulin solutions containing the same | |
| KR870002163A (en) | Preparation of Peptides | |
| DK193887A (en) | PEPTID WITH BRONCHODIL ARTS AND HYPOTENSIVE ACTIVITY | |
| ES8501364A1 (en) | Peptides. | |
| US4081434A (en) | Novel analogs of β-endorphin | |
| ES2074699T3 (en) | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS REAGENTS FOR BINDING PEPTIDES. | |
| MY106287A (en) | Acid addition salts of amidated taurine or glycine, their preparation and use | |
| Lemaire et al. | Synthesis and biological activity of. beta.-endorphin and analogs. Additional evidence for multiple opiate receptors | |
| JPS5657753A (en) | Novel glucagon fragment, and its use | |
| ATE1856T1 (en) | PEPTIDES WITH UBIQUITIN-LIKE ACTIVITY, PROCESS FOR THEIR PRODUCTION, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THEIR APPLICATION. | |
| IE900285L (en) | Peptides with sulphate ester groups. | |
| EP0123951A3 (en) | Intermediates for thymosin alpha 1 | |
| ATE120758T1 (en) | PEPTIDES, THEIR USE AS INHIBITORS AGAINST T-LYMPHOCYTE DEVELOPMENT AND EFFECTIVENESS OF MACROPHAGES AND METHOD FOR THE PRODUCTION THEREOF. | |
| Kawakami et al. | Synthesis of reaper, a cysteine-containing polypeptide, using a peptide thioester in the presence of silver chloride as an activator | |
| IE49755B1 (en) | Peptides having thymopoietin-like activity,therapeutic compositions containing them,and process for their preparation | |
| GB1532169A (en) | Fragments of secretin | |
| EP0307662A3 (en) | Enkephalin analogs | |
| KR850002834A (en) | Method for preparing basic hepta peptide vazopressin antagonist | |
| EP0001449A2 (en) | Analogues of somatostatin, pharmaceutical compositions containing them and their preparation | |
| IE893110L (en) | Peptides having t cell suppressor activity | |
| US4389342A (en) | Synthetic hormone-like peptides and method for their synthesis |